Vijayaragavan, Kausalia
Cannon, Bryan J.
Tebaykin, Dmitry
Bossé, Marc
Baranski, Alex
Oliveria, J. P.
Bukhari, Syed A.
Mrdjen, Dunja
Corces, M. Ryan
McCaffrey, Erin F.
Greenwald, Noah F.
Sigal, Yari
Marquez, Diana
Khair, Zumana
Bruce, Trevor
Goldston, Mako
Bharadwaj, Anusha
Montine, Kathleen S.
Angelo, R. Michael
Montine, Thomas J.
Bendall, Sean C. http://orcid.org/0000-0003-1341-2453
Funding for this research was provided by:
NIH (R01 AG056287, R01 AG057915, R01 AG068279, U19 AG065156, UH3 CA246633, P30 AG066515, T32 AI007290, T32 AI007290)
NCI (CA246880-01)
Stanford University (SGF)
Canadian Institute of Health (Research Postdoctoral Fellowship)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2ZHP3_181563)
Novartis Foundation for medical-biological Research (18B067)
Glenn Foundation for Medical Research (Postdoctoral Fellowship in Aging Research)
Article History
Received: 2 September 2022
Accepted: 18 October 2022
First Online: 4 November 2022
Declarations
:
: All human tissue used in our study will be de-identified archival material. No tissue will be acquired prospectively for this study. Consequently, these studies did not constitute human subjects research.
: Not applicable.
: MA and SCB are consultants for and shareholders in Ionpath Inc. that commercializes MIBI technology. MA and SCB are inventors on and receive royalties for patents relating to MIBI technology licensed to Ionpath Inc. YS was an employee of Ionpath Inc. at the time analysis was done on this manuscript. All other authors declare no competing interests.